NP-delivered intervention fails to reduce early symptom burden during chemo
the ONA take:
A nurse practitioner (NP)-delivered symptom management intervention did not appear to reduce symptom burden compared with standard care among patients initiating chemotherapy for nonmetastatic cancer, a new study published in the journal Cancer has shown.
For the study, researchers sought to determine whether an NP-delivered symptom management intervention would reduce patient-reported symptom burden among patients initiating chemotherapy for nonmetastatic cancer.
Researchers enrolled 120 patients with nonmetastatic breast, colorectal, or lung cancer and randomly assigned them to receive standard care alone or standard care plus the intervention.
Patients assigned to the intervention group received telephone calls from their oncology NP during the week after each of the first two visits for chemotherapy administration.
Results showed that 50.8% of patients reported at least one physical symptom at the time of the first chemotherapy administration visit. Researchers found that the number of symptoms, symptom distress, and satisfaction with care increased, while the risk for anxiety symptoms decreased.
The likelihood of depression symptoms did not change over time. There was no difference in the reduction of patient-reported symptom burden between the two arms.
The findings suggest that it is important to continue identifying strategies to improve symptom management, particularly early symptoms, during chemotherapy for patients with nonmetastatic disease.
A nurse practitioner-delivered symptom management intervention did not appear to reduce symptom burden.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|